BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 30202998)

  • 21. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR; Gargari BP; Farzadi L
    Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of synbiotic supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome: a randomised double-blind placebo-controlled trial.
    Karimi E; Moini A; Yaseri M; Shirzad N; Sepidarkish M; Hossein-Boroujerdi M; Hosseinzadeh-Attar MJ
    Br J Nutr; 2018 Feb; 119(4):398-406. PubMed ID: 29498342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Nasri K; Jamilian M; Rahmani E; Bahmani F; Tajabadi-Ebrahimi M; Asemi Z
    BMC Endocr Disord; 2018 Apr; 18(1):21. PubMed ID: 29649996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome.
    Jamilian M; Shojaei A; Samimi M; Afshar Ebrahimi F; Aghadavod E; Karamali M; Taghizadeh M; Jamilian H; Alaeinasab S; Jafarnejad S; Asemi Z
    J Affect Disord; 2018 Mar; 229():41-47. PubMed ID: 29306057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis.
    He C; Lin Z; Robb SW; Ezeamama AE
    Nutrients; 2015 Jun; 7(6):4555-77. PubMed ID: 26061015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Shabani A; Foroozanfard F; Kavossian E; Aghadavod E; Ostadmohammadi V; Reiter RJ; Eftekhar T; Asemi Z
    J Affect Disord; 2019 May; 250():51-56. PubMed ID: 30831541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
    Sanke S; Chander R; Jain A; Garg T; Yadav P
    JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome.
    Rahmani E; Jamilian M; Samimi M; Zarezade Mehrizi M; Aghadavod E; Akbari E; Tamtaji OR; Asemi Z
    Gynecol Endocrinol; 2018 Mar; 34(3):217-222. PubMed ID: 28949260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome.
    Khorshidi M; Moini A; Alipoor E; Rezvan N; Gorgani-Firuzjaee S; Yaseri M; Hosseinzadeh-Attar MJ
    Phytother Res; 2018 Nov; 32(11):2282-2289. PubMed ID: 30062709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.
    Velija-Ašimi Z
    Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
    Karadağ C; Yoldemir T; Yavuz DG
    J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W
    J Clin Lipidol; 2018; 12(2):417-427.e5. PubMed ID: 29454678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
    Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.
    Aroda VR; Ciaraldi TP; Burke P; Mudaliar S; Clopton P; Phillips S; Chang RJ; Henry RR
    J Clin Endocrinol Metab; 2009 Feb; 94(2):469-76. PubMed ID: 18984667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis.
    Zhang T; He Q; Xiu H; Zhang Z; Liu Y; Chen Z; Hu H
    Reprod Sci; 2023 Apr; 30(4):1033-1048. PubMed ID: 35941510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.